1. Home
  2. ALT vs NEWT Comparison

ALT vs NEWT Comparison

Compare ALT & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Altimmune Inc.

ALT

Altimmune Inc.

N/A

Current Price

$3.99

Market Cap

415.3M

Sector

Health Care

ML Signal

N/A

Logo NewtekOne Inc.

NEWT

NewtekOne Inc.

N/A

Current Price

$12.24

Market Cap

395.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ALT
NEWT
Founded
1997
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
415.3M
395.5M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ALT
NEWT
Price
$3.99
$12.24
Analyst Decision
Strong Buy
Hold
Analyst Count
6
3
Target Price
$15.50
$14.00
AVG Volume (30 Days)
2.8M
163.5K
Earning Date
06-10-2026
01-01-0001
Dividend Yield
N/A
6.29%
EPS Growth
25.37
N/A
EPS
N/A
N/A
Revenue
$41,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$756,308.50
$12.45
P/E Ratio
N/A
$5.99
Revenue Growth
105.00
N/A
52 Week Low
$2.91
$9.12
52 Week High
$7.73
$14.91

Technical Indicators

Market Signals
Indicator
ALT
NEWT
Relative Strength Index (RSI) 41.58 43.43
Support Level $3.78 $11.72
Resistance Level $4.25 $12.41
Average True Range (ATR) 0.24 0.46
MACD -0.07 -0.06
Stochastic Oscillator 41.64 49.05

Price Performance

Historical Comparison
ALT
NEWT

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About NEWT NewtekOne Inc.

NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.

Share on Social Networks: